Fed Decision On Deck… And Novo Nordisk Gears Up To Report 5/6/25

6 May 2025 · 44 min

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

Podcast Summary: CNBC's "Fast Money" Episode - Fed Decision On Deck… And Novo Nordisk Gears Up To Report

Episode Overview In this episode of "Fast Money," hosted by Melissa Lee and a panel of traders, the discussion centers around the upcoming Federal Reserve decision, the performance of semiconductor stocks, and the impending earnings report from Novo Nordisk. The episode highlights the current stock market conditions, potential economic implications from Fed Chair Jerome Powell's announcements, and concerns regarding the healthcare sector, particularly the weight loss drug market.

Key Topics Discussed

  1. Fed Decision and Market Reactions
  2. The episode opens with a focus on the anticipated Federal Reserve decision, with investors wary as stock market gains lose momentum.
  3. The Dow Jones Industrial Average showed losses, impacting all three major indices.
  4. Implications of Fed Chair Jerome Powell’s Speech:
  5. Expected to convey uncertainty in economic conditions, influencing market sentiment.
  6. Discussion on how corporate confidence contrasts with the Fed’s uncertainty.
  1. Earnings Reports: Semiconductor Sector
  2. AMD vs. Supermicro:
  3. AMD reported a stronger-than-expected performance with growth in data center revenue (+4% in after-hours trading).
  4. Supermicro, however, faced a drop in shares (-3%) due to lowered sales and earnings forecasts, indicating customer purchase delays and tariff concerns.
  5. Key Takeaways:
  6. AMD's guidance reflects confidence despite headwinds from U.S. export restrictions on AI chips to China.
  7. The contrasting performances raise questions about the overall semiconductor sector's health leading into NVIDIA's upcoming earnings report.
  1. Novo Nordisk and Healthcare Sector Concerns
  2. Novo Nordisk's stock price fell ahead of its earnings report, with analysts concerned about tariff implications and competition in the weight loss drug market.
  3. Analyst Insights:
  4. Discussion on the potential impacts of political risks and tariffs on the healthcare sector.
  5. The significance of Novo Nordisk’s partnerships and market strategies amid competitive pressures from companies like Eli Lilly.
  1. Additional Earnings Reports
  2. Palantir:
  3. Shares plummeted despite beating revenue expectations, citing a decline in international sales.
  4. Concerns about the sustainability of its stock performance given its high valuation metrics.
  5. Disney:
  6. Upcoming earnings report expected to highlight challenges from slowing consumer demand and tariffs.
  7. Analysts are scrutinizing Disney's strategy under CEO Bob Iger and its ability to navigate a challenging macroeconomic environment.
  1. Broader Market Dynamics
  2. Discussion on the implications of rising yields and the state of the credit markets ahead of Fed announcements.
  3. Richard Fisher, former Dallas Fed President, provides insights into the Fed's decision-making process and the implications of tariffs on economic health.

Key Takeaways

  • The episode emphasizes the uncertainty surrounding the Federal Reserve’s decision and its potential impact on market dynamics.
  • Diverging performances in semiconductor stocks suggest differing corporate strategies and sector health.
  • Healthcare stocks, particularly in the weight loss segment, face significant scrutiny due to political and economic risks.
  • The panelists express cautious optimism about corporate earnings amidst a backdrop of macroeconomic uncertainty, highlighting the need for clarity from the Fed and companies.

Conclusion This episode of "Fast Money" provides a comprehensive overview of the current financial landscape, including significant earnings reports and Federal Reserve implications, while also spotlighting the healthcare sector's challenges. The discussions reflect a blend of caution and strategic optimism, emphasizing the unpredictable nature of market conditions in the face of economic uncertainties.

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:02Live from the Nasdaq market site in the heart of New York City's Times Square. This is Fast Money. Here's what's on tap tonight. A tale of two semi-stocks, AMD and Supermicro, moving in very different directions after their latest reports. What they have to say about the state of the AI trade. We're dialed into the calls, bringing you all the details. And slimming down, shares of Novo Nordisk dropping ahead of earnings tomorrow. What the company could say about the weight loss drug space and looming tariffs on the industry. Plus, Palantir loses its top spot at the top of the S &P leaderboard. And what we should hear from the Magic Kingdom when Disney reports tomorrow morning.

0:33And Uber readies its own Q1 report. Will it widen its gap with rival lift? We'll debate that. I'm Melissa Lee. Come to you live from the studio. Be at the NASDAQ. On the desk tonight, Dan Nathan, Guy Dami, and Michael Schumacher, Wells Fargo Securities Global Head of Macro Strategy. Welcome to you, Michael. Well, stocks lower as investors get ready for tomorrow's Fed decision, the Dow leading the losses down almost a percent, but all three major indices extending their losses for the week. While 10-year yields tick lower, we'll get more on what to expect from the central bank in a few minutes.

1:00But we start off with a double dose of earnings from the semi-sector. AMD jumping on better than expected data center revenue while Supermicro falling after officially cutting its sales and earnings forecast for the year. Christina Parsonev, with Scott, all the details, is here on set. Hi, Christina. Hi, Melissa. I'm going to start with Supermicro because shares are under pressure, like you mentioned, over 3 % lower after the company delivered weaker guidance, even after last week's warning that they were going to do so. The CEO pointed to customer purchase delays for data center technology, though he attempted to reassure customers, or I should say everyone today in the release saying, We do expect many of those commitments to land in the June and September quarters, but cautioned that tariffs could create short-term headwinds for the AI server maker.

1:41Why are you seeing shares lower? AMD, on the other hand, popping over almost 4 % after hours on strong performance, specifically in his bread and butter business. That would be data centers and client segments. Traders are going to be listening closely on the call right now that begins about any hints about tariff-related demand pull-ins, similar to what Intel reported not too long ago. AMD's outlook is showing impressive confidence despite these headwinds, protecting$7.4 billion in sales while absorbing, and this we already know, the hefty$800 million hit from U.S. export restrictions to AI chips in China, which could be a lot bigger impact to revenue.

2:15This quarter, though, really just illustrates the tug of war playing out in AMD's business model right now. You've got traditional segment strength while China-related AI ambitions face these regulatory hurdles. Tune in, though, for more tomorrow at 9 a.m. when CEO Lisa Su joined CNBC's Squawk on the Street for her first post-earnings chat. Well, it's interesting, Christine. I mean, if you take these two reports, you can try and triangulate what NVIDIA might say on May 28th when it reports its earnings. I mean, of course, Jensen Huang spoke today. We'll get to some of that interview later on. But AMD, which is seen as sort of it would be heard more from the export restrictions out of China, actually did OK with that front.

2:52But NVIDIA is also very tied into Supermicro. So you have sort of a push and a pull dynamic. Yeah, I guess the portion of total revenues for AMD is a larger portion goes towards China. So that's the concern as well. Their latest AI chips, you know, haven't really the 300 series, MI300 series really is not up to par just yet. And so that's a concern. And there's a lot riding on the next 400 series chips that are coming out next year. So that is something for AMD to consider. Supermicro, though, what does that tell you about the company if they're delaying? Is it because of the hopper? Customers want to wait for the greatest server.

3:25Who knows at this point? You and Christina were just talking about Marvell pulling their basically June 10th investor day. I think they're postponing it. So I think about that and that juxtaposed with Christina with the fact that AMD actually gave good guidance for the next quarter. So you have to wonder how do they have that kind of clarity? I mean, I think it's encouraging because we haven't seen it in a while from AMD. And in the release, they said nothing about tariffs or a super micro blame tariffs for the short term. So you really have two sides of some saying, you know, addressing it head on.

3:53like Intel, whereas others are saying, no, we're not seeing any impact just yet, like TSMC, for example. It's also a little concerning, I would say. I don't know what your take on it. It's saying basically it's going to be sort of a back-end loaded year for Supermicro, right? A lot of these companies. How can you possibly say? I mean, if it's uncertain now, I don't know what the environment is going to be in a month or two. And yet, so then to your point, that could be applied to every single company out there. We keep asking and searching for these answers in the reports from these CEOs. And most CEOs are just saying, I don't know.

4:25You take these write downs,$800 million for AMD, 5.5 for NVIDIA. That's going to be a lot bigger and they don't have a crystal ball. Right. So I feel like everybody's searching for something that we're not getting a concrete answer just yet. So any bit of positive news is seen in the in the stock reaction. It's funny. So, you know, usually as a rule of thumb, you see, you know, AMD, they guide up three, four percent or something like that. The stock's up three, four percent. The stock's down 60 some percent from its highs last year. I mean, the market has basically said that these guys are not a player in this space.

4:54They're not a competitor for all intents and purposes to NVIDIA. But Kparts, when you put that together with this back-end loaded sort of situation, in my career, especially with tech, anytime you hear this is going to be back-end loaded, rarely does it materialize in the way that you're hoping for in the push-out. So I'm just curious, as you think about it as a mosaic, what we've heard over the last two weeks, do you find the semis, do you find what they've had to say encouraging as we lead into over the next two weeks with NVIDIA? Because, like to Mel's point, a lot really hangs on the balance for what, you know, I guess NVIDIA has to say.

5:25Quickly, to your point, AMD hasn't been, you know, very popular, so not very owned, which is why maybe you're seeing more positive reaction in the share price. I do feel that there's too much riding on the second half of this year. And I feel like that confidence is not going to follow through necessarily because there's the warnings from so many other of the non-AI plays. And I think we should really factor that in. Chips are cyclical, right? So NVIDIA may come out and do really well. AMD is a lot stronger. But overall, SMH, VanEck, ETF, just not doing as well. And so I think we have to remember the cyclical nature of these companies.

6:03Christina, thank you. Thank you. Christina Parts and Nevelis, how do you feel about back-end loaded guidance? Probably not very good. No, not good at all. I mean, think about that and contrast that with the Federal Reserve tomorrow, Melissa. So what is the Fed likely to tell us? Chair Powell is going to say we just don't know. And if we don't know, why should we act? So it's really flipping it around. Corporates seem more confident, at least given Christina's comments. The Fed, I think, will be much less confident tomorrow. You know, but I am interested to see, like, why, again, Marvell postponing a June 10th date, AMD being able to give guidance for a quarter.

6:33I mean, it's a tale of two cities right now. And I think, listen, AMD's been awful. We've actually talked about it. We've been pretty critical. But in my opinion, this quarter and the guidance is enough at least to get it back to the March high with if you pull up a chart, it was about 115. Yeah, the Marvell thing is not great for a couple reasons. One of the, I guess, headwinds to NVIDIA would be this custom silicon, right? The fact that Microsoft and these major hyperscalers, AWS, Google Cloud, they're working with companies like Broadcom and Marvell to create their own chips. We know that Google has their TPUs, this Tensor processing unit, right?

7:09So going forward, NVIDIA is going to have more competition. If AMD were ever to get their act together, if the performance of some of their chips are matching that of NVIDIA and then they can compete on price a little bit because they're trying to take some market share back. You know, a lot of things point to some headwinds as it relates to NVIDIA. We say this every quarter. We've done it for the last two years. You know, this is going to be a really important event for this AI trade. I just think there's been very few good headlines for NVIDIA. So they're going to have to put up a big beat and raise, I think, for this stock to keep going or kind of reverse the course lower to, you know, get back towards this high.

7:43Let's take a listen to what Jensen Huang had to say about China's AI market earlier today on Power Lunch. China is a very large market. It's probably going to be a$50 billion AI market in a couple of two, three years. It would be a tremendous loss not to be able to address it as an American company. It's going to bring back revenue. It's going to bring back taxes. It's going to create lots of jobs here in the United States. And that really underscores the point that they don't know. Because if it's going to be a huge market, it'll be a huge loss for companies like NVIDIA to not participate in that growing China market.

8:19Then export restrictions now will certainly hit them sooner rather than later. No question about it. I think he's been trying to sort of curry some favor with this administration. It all sort of makes sense. And listen, as the CEO of a publicly traded company, you have a fiduciary responsibility to do exactly that. The question is, you know, are they in the crosshairs right now? I will tell you, and Christina just mentioned in terms of the SMH, I mean, this is a space that is not traded particularly well. You've seen bounces along the way. But, you know, NVIDIA at 113, yes, it's bounced off the lows.

8:48But since January, it's not been a particularly good stock. These export controls, they're not about chat apps or picture apps or this and that or whatever, making them better. They're about, like, sovereign AI. They're about the very issues that we think about when it comes to investing in defense and the like. So if we're going to ship our best technology to China and we're going to actually be in the midst of a trade war, it just doesn't make any sense. So Jensen, go to Mar-a-Lago as much as you want to try to curry favor. At the end of the day, you know, there's more important things that are basically going to kind of have to take hold of this industry pretty soon, whether it's a year or two.

9:20And we've been talking about this. There is going to be considerable regulatory oversight of this industry. It needs to happen for all the reasons we're talking about. really from a national security standpoint. Yeah, it's hard to make the case with just massive tariffs on China that the administration's tone is going to shift anytime soon. We're not getting any sense of that. Are they actually talking to China? We don't know. Besson said, well, sort of, maybe, kind of, not clear. So what's the time frame? Don't know. What's the outcome? Probably not good. Well, the 10-year yield dropping after better than expected demand at today's Treasury auction.

9:49The results calming fears that foreign buyers are avoiding U.S. debt as a protest against tariffs. The move in rates coming ahead of tomorrow's Fed decision, the first since President Trump announced sweeping tariffs at the start of April. Let's get more on what we can expect from the Fed tomorrow, bringing CNBC contributor and former Dallas Fed President Richard Fisher. Richard also served as U.S. trade representative and is now a senior advisor at Jeffries. Richard, it's always a pleasure to welcome you to Fast Money. Great to have you. Honored to be with you guys. What do you think the Fed should do?

10:19Not what the Fed will do, should do. I think it's like any other business. They can't make a decision here given all the uncertainty. How do you model out the economy going forward and make decisions where you don't know what the variables are? So I don't expect anything tomorrow. And I may not even be expecting anything in June. We'll have to see. We need clarity. If we don't have clarity on what's going to impact the economy, then I can't see them making a firm decision here. When do you expect the impact of tariffs to flow through to the hard data? Some economists are saying May, which would give them a possible data point for that June meeting coming up.

11:02You know, it really depends. Agreements in principle don't give you much guidance. I'm expecting them to make some announcements. Let's say they do an agreement in principle with Korea. Korea's in the middle of an election cycle. They have to go to their own legislature. They I negotiated the opening of Vietnam when I was in the Clinton administration as deputy U.S. trade rep. You know, when it was finally signed, we got all the specifics done after four years of work by the Bush administration. So these things and every manufacturer I talk to and every business I talk to, what they're interested in are the specifics, not just the grand sweeping statements.

11:42So I think market operators need to be very, very careful here. If we get these announcements, it doesn't tell you very much. It tells you intent. And then the nuts and the bolts have to be worked out. We have a very good USTR right now. It may be that he can move us faster than anybody else been able to do before him. But we'll just have to see. Hey, Dick, when you were a Fed president, I assume that there were times in which you would vote within that room. And, you know, a lot of what goes on there, from what I understand, is the Fed chair tries to kind of rally support for a different view.

12:16If you were considering what the dissenters would have to say, like, help us think through that right now, because it seems to be one of these things where it makes sense to most economists not to move right now. But I'm just curious if you were in the room, where would some of that dissent come from? Well, I think they're first of all, Jay Powell's been able to hold this group together pretty well. The dissent often comes from an honest disagreement. It's not harsh. I happened to dissent a few times and others did the same thing. And then typically the chair will acknowledge your dissent, but then ask you if we are going to proceed as we have written it up.

12:59How would you make this better? You understand what we're trying to get done here. You've been overruled. Help us put into effect whatever we have decided. And so you work on the wording a little bit. We used to have a straw vote all the time. Bernanke was very good about that. Yellen was very good about it. And it was in that way that the statement gets formed. So were I at the table right now, by the way, I'd be arguing we don't have the clarity to make a decision. But I'm not at the table. I'm a retired dot, by the way, a former plotter. So, by the way, I hope we're going to talk about energy because there's a lot going on in that sector.

13:40We'll get to that in a minute, Richard. Trying to avoid this forecasting of what they're going to do. When you think about the Fed not moving tomorrow and probably not in June, it sounds like that sets the stage for the Fed to have to go bigger later. So almost bakes in the Fed being late and increases the chance that the economy tips toward maybe it's recession, maybe it's just a bad result. but the Fed has to get really aggressive late in the year. Do you think that's right? Do you agree with that line of thinking? I don't know. I mean, we'll just have to see. First of all, a lot of data has to come forward before June, perhaps more clarity.

14:17We'll just have to see as this goes through time. It's unusual for the Fed, except for under dire circumstance, to make a dramatic move. And really what you're looking at when you're at the table is the health of the credit markets. It's not the stock market. Of course, you're worried about inflation, deflation, employment, unemployment. But the one thing that could force them to move dramatically is always going to be if the credit markets seize up, which is what we saw in 2008, 2009, what we saw in March of 2020. And then you announce a new facility as well as perhaps rate cuts. So don't forget, they're also trimming the balance sheet, but that's slowed down.

14:57They're getting close to the right size. So there are several tools you can employ to make announcements. You can create new facilities if you need to. They may not even be used, which is what happened in 2020. Or you can cut rates. So we'll have to see. Mr. Fisher, you know I'm a fan. Have you noticed what's going on in the energy space? I mean, oil has obviously been a story. And I'll say this real quick. I mean, 10 years ago, this is probably not great for Texas, but the state has diversified maybe enough where they can withstand its thoughts. No, I think you're right. And let me just walk you through this, because, again, Jeffries, which I happen to be senior advisor to, handles 50 percent of all the transactions in the oil and gas and energy sector in the United States and is number one globally.

15:40So we talk about this a lot. You know,$56,$57 oil. What's going to happen there is the U.S. producers are just going to lay down their rigs. At the same time, by the way, they're suffering from the inflation and the cost of pipe and the cost of sand and all the things, nails and screws have gone through the roof. You have to build a rig with. So I think basically, as someone has often said, low prices are cured by low prices. So I think they will lay down their rigs at these prices. They're not going to proceed. They're getting twisted by inflation as well. And one of the interesting things, though, is we're seeing natural gas prices rise significantly.

16:24And that's due to the expectations of what's going to finance or rather fuel AI. So we'll just have to see what happens here. But I think we have to be careful. Drill, baby drill, sounds good. I hope it works. But it doesn't seem to be working. And the oil patch guys that I talked to are not terribly happy. Now, what you have to understand about the Texas economy is oil and gas and mining, in terms of employment, only employ 1 % of our working force in Texas. We are thoroughly diversified. And we now, of course, in North Texas have become a financial center, with Goldman Sachs having 5 ,000 people down here, J.P.

17:07Morgan having more people in North Texas than they do in New York. And if you listen to Jamie Dimon or you listen to guys at Goldman or you listen to guys at Jeffries, we're saying this is where the future lies. And, you know, I would urge you to take a look at what just happened today. And if you go outside the New York Stock Exchange today, you'll see people demonstrating to increase the transactions tax and restore it. And I think that's what the governor of New York wants to do. What do we do today by a huge majority in the Texas Senate and House? We made a constitutional amendment that we will not financial transaction taxes.

17:49And in addition to that, we changed the shareholder laws to compete with Delaware and Nevada. And so a lot is going on here. It's just acknowledging the fact that we are very diversified, in fact, equally diversified to the rest of the economy. And the service sector, particularly financial services, is playing a huge role here, which is why people have moved in this direction. So it's not just oil and gas in the tax economy. Please understand that. But what's happening in that sector is there's a slowdown. Again, U.S. producers are going to lay down their rigs if we stick in the$56,$57 range.

18:27Yep. Richard, great to get your perspective. Thank you so much for joining us. I'm sorry to be such a Texas chauvinist, but that's me. Well, you know, we called you out because we wanted to get that perspective. So we do appreciate it. Thank you, Richard. All right. Thank you all. All right. Richard Fisher. Michael, do you think that cuts are back and loaded? Should we be prepared for that? I do, actually. Yeah, we do think the chance of pretty much what I laid out for Dick Fisher is coming to fruition. And the Fed will wait, wait, wait. It'll get clarity. Clarity will be not very good. So it'll have to come in and go pretty aggressively.

19:00Yeah. So I think chance of a hundred odd basis points second half of this year, it's increasing by the day. Wow. Four cuts by the end. I mean, that's, you know, again, what is that predicated on? Because the data has been soft, but it hasn't been catastrophic. And so I'm in the camp where less is more at this point. And I think you're going to hear, I think, a pretty hawkish Fed tomorrow, which will not make the administration happy. But I think that's the way they have to be. How will the markets interpret a very hawkish Fed? Not good. I don't think it will be good, but that's me. Yeah, silver lining over here.

19:29I mean, the market's down a few percent, right? We just got that jobs number. GDP is going to be explained away. Interest rates, 10 years, basically the exact same spot it was a year ago. I mean, you can make the argument if you just looked at Q1 earnings and Q2 guidance. I saw some data from FaxEd today that it's a remarkably low list of companies that actually pulled their guidance. Now, we just saw what Mervell is doing and some of these others. So if you just took a snapshot right here, you can say to yourself, OK, maybe we priced in the worst case scenarios that was in early April. That's the silver lining.

20:02The flip side of it is I'm probably more inclined to take Paul Tudor Jones's view about equities not really pricing in. You know, kind of a little worse than base case scenarios. You don't need worst case scenarios. And the other thing about yields, I mean, they cut rates 100 basis points in September, November and December. You know what I mean? So I don't even think back end loaded 100 basis points seems so aggressive. it. Still, I mean, if you look at other markets, too, think about the currency markets going absolutely crazy in a lot of respects. Yen's been all over the place. Taiwan dollar.

20:30When's the last time you talked about the Taiwan dollar in the show? Probably not often. Six percent in a couple days. Euro's gone nuts. We were talking about parity for euro dollar at the beginning of the year. Now it's 113. Big signals there, I think, that are tough to miss. All right. Coming up, more earnings action to bring you shares of Rivian, Wynn, Electronic Arts, all on the move after reporting the numbers. We got the full details from the quarters next. And speaking in results. Palantir plunging after their earnings report last night. Why an earnings and revenues beat was not enough to thrill investors and who they're teaming up with to bring AI into your finances.

21:00Don't go anywhere. Fast Money's back in two.

21:11Welcome back to Fast Money. We got an earnings alert on Rivian. Shares, the EV maker falling after cutting its forecast. CNBC's Phil Lebeau's got the latest. Phil. Hey, Melissa, good news, bad news in the Rivian Report. Let's give you the good news off the top if you're a Rivian investor. A smaller than expected loss for the first quarter. They lost 41 cents a share. The street was expecting them to lose, what, 76 cents a share. Gross profitability,$206 million. Why is that important? Two consecutive quarters with gross profitability means they unlock another$1 billion in financing from Volkswagen.

21:44Now the bad news, and it has to do with the guidance when it comes to deliveries. The company has cut its 2025 delivery guidance to between a range of 40 and 46 ,000 vehicles. Just last month, their guidance was 46 ,000 to 51 ,000. What changed? Call it uncertainty. Uncertainty with the consumer, uncertainty with tariffs. Here's CEO RJ Skaring last hour. But as you said, there's a lot of uncertainty, and both in terms of our cost structure on CapEx, that's equipment we're buying. with the trade and tariff situation. We are reflecting more CapEx spend for the same content. And we're also looking at the overall consumer sentiment just more broadly in conjunction with what's happening around trade.

22:30As you take a look at shares of Rivian over the last three months, keep in mind that they do maintain that they are on track to open the new plant that they are building in Georgia that will build their more affordably priced vehicle that will happen next year. Quickly, I want to take a look at shares of Lucid. They posted a smaller than expected loss of 20 cents a share below the street estimate. The revenue coming in at$235 million, which is shy of what the street was expecting. But there is some optimism here because, Melissa, they have affirmed their guidance of building 20 ,000 vehicles this year.

Read the full transcript

23:04That's the two EV makers. Back to you. Guys, I've got a question. Yeah. I'm sorry. I'm sorry for everybody. Real quick. It's a rounding error for Amazon Venture, but they have like a 14 percent stake in Rivian. I guess my question to you is, right. What's the game plan? Like, why? Well, they get electric delivery vehicles from Rivian, and I suspect it's not just to get those vehicles from Rivian and to be the primary customer there. My guess is that they plan on using Rivian and its expertise when it comes to not just electric vehicles, but electric architecture in the future, in other endeavors as well, beyond the delivery vehicles that you see out on the street.

23:47So I ask that question because would it be logical at some point, now I'm asking you, for Amazon just to say, you know what, this makes sense for our ecosystem. I don't know, I'm just throwing it out there. For self-driving. Yeah, for a lot of different reasons. It's going to become a super app, basically. It reverses into being a super app. So it's not as ridiculous as it, you know. Anyway, I'm just throwing it out there. Phil, thank you. Phil LeBeau. We will remind viewers, but I'm sure that they keep track of your acronym from year to year to year to year, because way back when Rivian was in one of your acronyms.

24:18Yeah, I mean, the whole idea, and Phil mentioned this, is like the bright spot is that they're losing less than folks expected. And, you know, this story, and I made this case, is not too different than, let's say, Tesla in 2009, 2010, 2011. When you talk about some of the delivery numbers that they're talking about, I mean, this is just a flyer. If you think that this is going to be a big market, and this is purely anecdotal, but people in California are buying Rivians over then going out and buying Teslas right now. And then Tesla in California, first time they dropped below in the quarter that we just reported, 50 percent as far as market share is concerned.

24:49Now, Rivian nationally is like 5 percent market share. Right. So, you know, there's a lot of opportunity there. They have to cut the losses. even if they're not making or delivering a whole heck of a lot of cars, if they demonstrate that they can actually do this on a path to profitability, that was Tesla's whole story. So to me, you know, is it that attractive given what the EV market looks like? And if we're quoting Dick Fisher about the energy market, I think when crude oil goes to 50, I'm not saying it goes to 50, EVs are just that much less attractive. This is actually the second consecutive quarter with positive gross profit for Rivian.

25:19And it's got, I mean, a key difference is that, but also it's got a lot of cash versus Tesla at that similar stage, right? A-nap billion is nothing to sneeze at at this point. Coming up, no longer the king of the hill. Palantir's post-earnings drop knocked it out of the top spot in the S &P 500 this year. Is the high flyers dropped just a breather or a sign of more pain to come? You're watching Fast Money Live from the Nasdaq Market Side in Times Square. Back right after this.

26:12We'll be right back. a show ever. So to find out how to navigate this wild market environment, get your tickets now. Just scan the QR code or go to CNBCevent.com backslash fast money.

26:27Welcome back to Fast Money. Shares of Palantir dropping hard after reporting quarterly results yesterday. The defense tech company beating top and bottom line expectations, but posting a decline in international sales. The company also announcing a partnership with Elon Musk's XAI to bring AI into the financial services sector. Palantir has surged more than 300 percent over the past year. But today's move knocking the high flyer out of the top spot in the S &P 500 in 2025. What do you think of the slide here? Makes sense. I mean, this is in my nearly 30 years in the business, probably the most obscene stock I've ever seen.

27:00And when you think about this, it's trading at 66 times sales. If I told you that was a PE, you might think that that's a little insane. Now, the good news for them is that their earnings and sales estimates went up. And so maybe that helps justify some of the valuation, but not at 170 times earnings and 66 times sales for the current. The one thing I'll also say about that international sales is like if we have export bans on key chip technology, right, and 50 percent of their sales comes from the U.S. government. If you are a foreign buyer of this technology, there's potentially interesting dynamics there.

27:33A, you might not choose to use it. I don't know if this is like the whiz-bangiest best technology there. I think it's somewhat of a first mover. And then might there be some bans on this sort of stuff? Might there be some folks that just don't want to buy U.S. stuff? We keep hearing that more and more. With less than a$4 billion revenue expectation for this year, it just doesn't make any sense to me. We've got breaking news out of the White House here. President Trump just making some comments from the Oval Office. Megan Cassell has got the details. Megan. Hey, Mel. Also, President Trump, for the second time today, talking about the status of trade deals and making clear that his view of what a trade deal will look like in the coming days is something different from what most markets, investors and businesses have been expecting.

28:13Take a listen here to exactly how the president responds when he's asked about the status of forthcoming deals. Mistreated. One was in for 512 days. One was in for 361, I guess, days. And one was in for a shorter period of time. The stories were unbelievable. I said, how many people are left? How many are left? They said 59. I said, oh, wow. And people, and they said 59. And I said, really? But they said. He said there that he could announce 50 to 100 deals right now when he was asked about this, saying that because he's the shopkeeper and he sees the U.S. as a store. When he spoke about this earlier today, he made clear he does not see any downside to cutting off all trade with China or with any other country.

29:03He thinks of it as no longer having a trade deficit. So that means we're not losing money anymore. So just at this moment when everyone has been waiting for trade deals, when his administration has been talking for days now about deals that could be forthcoming, he's saying that the deal that he wants to see is simply naming a price, potentially a tariff, for countries to have to pay in order to have to shop, his words, in the United States. that he could announce those at any time, and maybe he will announce some, but it's not something that would have to be signed, and it's not likely to be any sort of formal or enforceable agreement.

29:35Melissa? So can you help us compare and contrast some of the language used by other members of the administration regarding what they believe a time frame is? Because it sounded like it was a lot more concrete when Secretary Besson was speaking to Sarah yesterday, or Howard Lutnick was quoted on another outlet earlier this week. They've been telling us for several weeks now that deals are very, very close, potentially in the next few weeks. Scott Besant was on Capitol Hill today talking with lawmakers. He said he thinks 80 to 90 percent of all of the deals should be finished by the end of the year.

30:05So something of a long timeline, but significant when you think about how many countries they are negotiating with and that he would not be surprised if one of those even came this week. Besant also said today that something he's said before, but repeating it today, that negotiations are moving forward with what he calls 17 of our 18 largest trading partners. But he said very clearly negotiations have not yet begun with China. So other administration officials signaling that sort of more significant deals could be forthcoming. And we know officials have been here for negotiations almost being undercut here by the president, who says 50 to 100 deals could be announced immediately if he wanted to do it, that all that matters is that countries are paying some sort of a price to come do business in the U.S.

30:47Right. Megan, thank you. Megan Casella. It sounds like there's a lot going on there in Washington with a lot of the trade partners. But the issue for the markets is there's no it's a moving target, it seems, Michael. There's no there there. I mean, the markets are going to want a lot more clarity than that. And I've talked to a lot of corporates recently, which I have to tell you, Melissa, generally is a bad sign. People want to talk to me. It's because something's probably broken. And oh, well, you're the exception guy. I appreciate that. But nonetheless, when you think about actually having just Donald Trump or let's say Trump and Carney get together, as they did today, have some sort of announcement, say we agree on next tariff.

31:24Well, that could change tomorrow or next week or two weeks out. Companies want something they can actually plan around. I would tell you that if tariffs were put in place right now and the president came out and said, look, I'll leave them as is for the rest of my term, it would still take a while for people to believe that. They'd say, all right, let's see how he actually behaves. So my view is it's a bit of scarring going on. It takes time to get over that, but it's not 50 or 100 deals get announced this week or this month. That's really far-fetched. There's a wonderful show on this network from 6 a.m.

31:51to 9 a.m. Are you familiar with that? Squawk Fox. The Squawk Fox. I love the host. Dan's favorite show also. No doubt. But it's also Paul Tudor Jones was on today. And I encourage people to listen to just what Megan said and all the things we're talking about. And now, not juxtaposed, but listen to what Paul Tudor Jones said this morning about the ability to cut these tariffs back by whatever percentage. And he still thinks this is a market that's going to make, you know, lows lower than we saw on April 2nd or 3rd. Coming up, pharma in focus as the FDA names a new top vaccines official. Why that pick is turning a few heads and what to expect out of Novo Nordisk, a head of results tomorrow.

32:29All that when Fast Money returns.

32:38Welcome back to Fast Money. the FDA making a controversial pick to lead its biologics and vaccine division. Our Angelica Peoples has got the details on that. Angelica. Hey, Mel. So, yeah, FDA Commissioner Marty McCary naming Vinay Prasad as director of the Center for Biologics Evaluation and Research. So in that role, he'll oversee the regulation of biologic drugs, vaccines and the nation's blood supply. Now, Prasad's day job is a professor and doctor at the University of California, San Francisco. but among biopharma, he's better known for his very active online presence. He has a substack, he's all over X, you can hear him on podcasts, and there he's quite vocal about his criticism of the FDA.

33:18So he's accused his predecessor, Peter Marks, of rubber stamping unproven products, and he wants to see harder outcomes for drugs, like a survival benefit for cancer drugs, that would require longer studies and, of course, much more money to run those trials. He's also skeptical of accelerated approvals, a pathway that Duchenne muscular dystrophy drug maker Sarepta has used. Look at that stock, down 24 percent after hours and it got hit especially hard today during normal hours. He's also criticized the COVID vaccine rollout, particularly the use of boosters. He's thrown doubt on cancer vaccines.

33:51And that's a double whammy for Moderna since they, of course, have their COVID vaccine and they're also developing a cancer vaccine. That stocked down about 12 percent today. and he's critical of gene therapy. So Verve, Intelia, Beam, those are just some of the names that fell hard today on news of his appointment. So really broad impacts that we're seeing across the board today, Mel. All right, Angelica, thank you, Angelica Peoples, for more on all that as well as what to expect from Novo Nordics tomorrow. Let's bring in BMO Managing Director and Head of Healthcare Research, Evan Siegerman. Evan, great to have you with us.

34:22Thank you for having me. We've seen the reaction in the stocks. We saw the reaction in the biotech sector in general.

34:29It was appointment. It sounds like everything that he is advocating or advocating against will cost these companies a lot more money to bring drugs to market. Is that the bottom line? Most definitely. And I think he's a general skeptic of the industry, of all the things that FDA has kind of come up with to get drugs approved faster, accelerated approval, single arm trials for rare disease. He's a big skeptic, of course, of the COVID vaccines for those who are not immunocompromised and really at risk. So I think that there's just an overhang for the sector now. I mean, he's saying that he would want randomized trials of the boosters because otherwise you might, you're not testing every strain of the vaccine and therefore it can cause all sorts of side effects that we don't know about.

35:09But you can't even really do a randomized trial for the booster at this point. It's not really ethical and there's not enough COVID circulating around. So you have to just figure out where you're going to pick your battles. Okay. How, I mean, the sector is one that has struggled under negative sentiment. this just adds to it. Is this investable? I think the biopharma sector, I think, is investable. Human health is very important. I think we definitely have a lot of headwinds. Pharma tariffs, which we can talk about as well, have been an overhang and a theme of earnings. And if you listen to any management team over the past earnings cycle, they don't know the answer because I don't think anyone does.

35:43We have NOVO reporting tomorrow, which we'll touch on. You know, I could see them get hit with some tariffs as they make their product overseas. But I do think the sector is investable, but we are definitely facing headwinds. Well, that was going to be my question. Is Novo out of the woods? I mean, we've talked about it now for a while. I've been wrong for probably$40 to the downside. But has it found a place where, you know, good news is going to be sort of championed and bad news is sort of in the stock already? So last week we had two bits of good news. One, they indicated that they're offering their$4.99 on WGOVI on all tell-all platforms we saw with HIMSS.

36:18And then also got an exclusive deal with CVS Caremark, where Wagovi is the exclusive anti-obesity medication as of July 1st for many of their formularies. Tomorrow, what I'm focused on, trends with GLP-1, so Wagovi. Script numbers have not looked good, and I think a lot of folks are concerned that they might have to cut the guide. But do they punt that to 2Q because they're going to point to compounders going away March 20 and May 22nd? And, of course, this CVS kind of formulary bit. So we could see them, you know, numbers could be squishy. They may punt it. And I think, to your point, that makes it a bit harder to invest in.

36:57I'm also concerned about Orfaglipron. We had some data from Lilly a few weeks ago. We got more on 3Q. Would you rather Eli Lilly or Nova right here, right now? Eli Lilly. Okay. You know, I think Dave Ricks really understands the moment when it comes to the political side of things. Orfaglipron is going to be a fantastic drug. We have the data. Evan, great to see you. Thank you. Thank you for having me. We're in BMO. Coming up, what to expect out of Disney's earnings report tomorrow, and how are traders see that stock bearing after a rough start to the year at the trade when Fast Money returns?

37:33Welcome back to Fast Money. Disney on deck to report earnings before the belt tomorrow. The media giant already facing potential headwinds from slowing consumer demand. Could now have to also contend with tariffs on the film and streaming industry. Julia Borson has more on what to expect from tomorrow's results. Julia. Hey, Melissa. Beyond Disney's fiscal Q2 earnings, the big question is what CEO Bob Iger says about how Disney is positioned to ride out a downturn, given its exposure to the macro environment and new potential threat of film tariffs. Disney has three key areas of exposure to consumer and corporate spending.

38:05First, its Parks and Experiences division, responsible for 60 percent of Disney's operating income. The parks recently raised prices and would be hurt by a pullback in foreign travel. Second, Disney's ad revenue on linear and streaming, which Morgan Stanley warns, will suffer from broader ad softness as a result of economic uncertainty. And third, there's the question of how much its streaming business could suffer from a pullback in consumer spending. After Disney Plus lost subscribers last quarter following a price hike, the company did warn it expects to see continued churn in Disney Plus this quarter.

38:38Morgan Stanley writing that they believe a lot of macro risks for Disney are already priced into the stock, saying, quote, with shares down 20 percent year to date, the net result is an attractive risk reward, but one that may take time to play out as the market looks for visibility into the degree, if any, a weaker macro impacts earnings. And Raymond James writes that while Disney's parks make it more exposed to broader potential economic pressure or travel impacts, They also insulate Disney from potential pressure on the entertainment division, including the issue of international tariffs. Now, analysts are bullish that Iger will show progress in his goals to grow streaming and continue turning around the studio.

39:19Seventy five percent of analysts have a buy and 22 percent have a hold on the stock. Back over to you. All right, Julia, thank you, Julia Boorstin. And I guess that's a key question. How much is Disney priced in and how do you gauge what's priced in? And if we don't really know what that macro environment is going to be in the second half of the year. There's no way they can know. I mean, a lot of me clearly. If you think about what we believe to be the slowdown of the consumer, I mean, Disney does not win there. But at$92 is a price in. I think this is a really important quarter. The second iteration of Bob Iger has not been particularly good.

39:50He actually has to start to deliver. And I think tomorrow's a quarter they're going to do it. Yeah, the macro risk is high, Melissa. We've been talking about that all show. It's not going away. Disney seems exposed. I'll leave it to these gentlemen to talk about the stock per se. But in general, the uncertainty level is so high. And I was thinking about those three components of the business. Each one is impacted a lot by events in D.C. How can you really have a lot of a good window into those? You see what he just did? Yeah. He called us gentlemen. Bond calls us panelists. Well, I know. I know.

40:19Both are laughable for different reasons. No, no. Gentleman is nice. I mean, I'm down with that. Thank you, Michael. Absolutely. You're a gentleman. The thing about Disney is that it hasn't gone anywhere in 10 years. You know what I mean? And trading near this level is trading where it was at the lows of COVID. Think about the height of uncertainty. Now, it did double from there. You know what I mean? And that was a bit of a COVID sort of frenzy. But I think to your point, I mean, Iger's got to pull a rabbit out a hat. And there's lots of hats right now like that need to be pulled. So I think this is a tough one.

40:47Coming up, it's not just Disney on deck. Two rideshare stocks getting ready to report this week as well. Our traders are setting up ahead of Uber and Lyft results next. Fast money's back in two.

41:04Welcome back to Fast Money. We are getting ready for two rideshare reports. Uber results due out tomorrow before the bell. While Lyft's numbers will cross Thursday afternoon, the name's really diverging in 2025. Lyft shares flat for the year, while Uber's surged more than 40%. Uber, of course, and I don't have to remind the viewers, is the UN tube. No, it's really doing justice to my tube this year. I mean, Uber and Alibaba. This is where it gets really interesting, right? I mean, we had that huge run-up earlier in the year, then a precipitous sell-off on the back of some news about, I think, Waymo and some news about Tesla and all different things.

41:40Stock got right back on its horse. Valuation is a little stretched. We're at prior highs, but I think Uber is going to continue to surprise people to the upside, Melms. Is it better because it's diversified? Probably. I mean, DoorDash had some interesting results this morning. They had to make a couple acquisitions that I thought were pretty interesting. So they're trying to broaden out their scope geographically. I mean, I think, you know, Herber Eats, which a lot of folks were not happy about shareholders when they bought it. I think it's been a really important business. You know, Lyft is one that it just it's been in a lot of our acronyms over the last few years.

42:11And shoved into them, too. Like after the fact, it still didn't work out. Wasn't pretty. But, you know, again, this is one that's got a five billion dollar enterprise value and they're sticking around. And I think it's important to have a number two player here. But I still think that they're an acquisition target for somebody who wants to build some form of fleet technology in the robo space. Up next, final trades.

42:40Time for the final trade, Michael Schumacher. Yep. So U.S. Treasury yields, Melissa, up a little bit tomorrow because Powell's hawkish, maybe five basis points in the 10-year. but over the next three months down. So we'll put the 10-year just below four, three months down. All right. Thanks for joining us, Michael. Dan? Nice to have a proper gentleman on the desk. I mean, lift. I think if it gaps down towards 10, I think you might. Guys. A collective happy birthday to Tim Seymour. Steely-eyed. Southwest Air Milk comes out, love. All right. Thanks for watching Fast. Matt and Bonnie at Jim Cramer starts now.

43:12All opinions expressed by the Fast Money participants are solely their opinions and do not reflect the opinions of CNBC, NBCUniversal, their parent company or affiliates, and may have been previously disseminated by them on television, radio, internet, or another medium. You should not treat any opinion expressed on this podcast as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion. Such opinions are based upon information the Fast Money participants consider reliable, but neither CNBC nor its affiliates and or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such.

43:46To view the full Fast Money Disclaimer, please visit cnbc.com forward slash Fast Money Disclaimer.

From the publisher

Another key Fed decision on deck, as the recent stock market bounce loses steam. What to expect from Fed Chair Jerome Powell, and what it will mean for the market’s next move. Plus Earnings season in full swing, and Wegovy-maker Novo Nordisk is ready to report. Why one top healthcare analyst is eyeing potential tariff risks and political overhang as a headwind for the whole weight loss drug space.

Fast Money Disclaimer


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

More from CNBC's "Fast Money"

All 871 episodes
Fed Decision On Deck… And Novo Nordisk Gears Up To Report 5/6/25CNBC's "Fast Money" · 44 min
Listen in VO